Näytetään tulokset 1 - 10 / 1460
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi

A Nordic survey of CT doses in hybrid PET/CT and SPECT/CT examinations

Vertaisarvioitu
Avoin saatavuus
DOI
10.1186/s40658-019-0266-7
Bebbington, Natalie A.; Haddock, Bryan T.; Bertilsson, Henrik; Hippeläinen, Eero; Husby, Ellen M.; T...
EJNMMI physics2019

The value of 18F-FDG-PET-CT in the management of infective native aortic aneurysms

Vertaisarvioitu
DOI
10.1177/1708538120987971
Hannsberger, Daniel; Heinola, Ivika; di Summa, Pietro Giovanni; Sörelius, Karl
Vascular2021

FDG‐PET/CT‐guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma

Vertaisarvioitu
Avoin saatavuus
DOI
10.1002/cam4.4924
Rajamäki, Aino; Kuitunen, Hanne; Sorigue, Marc; Kokkonen, Salla‐Maarit; Kuittinen, Outi; Sunela, Kai...
Cancer medicine2022

Hybrid SPECT/CT and PET/CT imaging

Vertaisarvioitu
DOI
10.1007/978-1-4614-5551-6_3
Knuuti J
Springer2013

Ga-68-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism

Vertaisarvioitu
Avoin saatavuus
DOI
10.2967/jnumed.121.262327
Boss, Marti; Rottenburger, Christof; Brenner, Winfried; Blankenstein, Oliver; Prasad, Vikas; Prasad,...
Journal of nuclear medicine2022

TKTL1 as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma and Its Correlation with FDG-PET-CT

Vertaisarvioitu
Avoin saatavuus
DOI
10.1159/000510862
Ahopelto, Kaisa; Saukkonen, Kapo; Hagström, Jaana; Kauhanen, Saila; Seppänen, Hanna; Böckelman, Cami...
Oncology2021

Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.1007/s00259-021-05296-1
Malaspina, Simona; Anttinen, Mikael; Taimen, Pekka; Jambor, Ivan; Sandell, Minna; Rinta-Kiikka, Irin...
European journal of nuclear medicine and molecular imaging2021

Hybrid SPECT-CT and PET-CT: Current concepts and development

Vertaisarvioitu
Knuuti J ; Saraste A
Current cardiovascular imaging reports2011

Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.

Vertaisarvioitu
DOI
10.2967/jnumed.111.094771
Kauhanen S, Schalin-Jäntti C, Seppänen M, Kajander S, Virtanen S, Schildt J, Lisinen I, Ahonen A, He...
Journal of nuclear medicine2011

Hybrid PET-CT Evaluation of Myocardial Viability

Vertaisarvioitu
Nammas W; Saraste A
Springer, Cham2022

A Nordic survey of CT doses in hybrid PET/CT and SPECT/CT examinations

Vertaisarvioitu
Avoin saatavuus
DOI
10.1186/s40658-019-0266-7
2019

The value of 18F-FDG-PET-CT in the management of infective native aortic aneurysms

Vertaisarvioitu
DOI
10.1177/1708538120987971
2021

FDG‐PET/CT‐guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma

Vertaisarvioitu
Avoin saatavuus
DOI
10.1002/cam4.4924
2022

Hybrid SPECT/CT and PET/CT imaging

Vertaisarvioitu
DOI
10.1007/978-1-4614-5551-6_3
2013

Ga-68-NODAGA-Exendin-4 PET/CT Improves the Detection of Focal Congenital Hyperinsulinism

Vertaisarvioitu
Avoin saatavuus
DOI
10.2967/jnumed.121.262327
2022

TKTL1 as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma and Its Correlation with FDG-PET-CT

Vertaisarvioitu
Avoin saatavuus
DOI
10.1159/000510862
2021

Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.1007/s00259-021-05296-1
2021

Hybrid SPECT-CT and PET-CT: Current concepts and development

Vertaisarvioitu
2011

Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.

Vertaisarvioitu
DOI
10.2967/jnumed.111.094771
2011

Hybrid PET-CT Evaluation of Myocardial Viability

Vertaisarvioitu
2022